Dr. Agarwal's Health Care · NSE: AGARWALEYE · BSE: 544350
Q4 FY25 results · Jan–Mar 2025
Dr. Agarwal's Health Care reported revenue from operations of ₹460.22 crore and net profit of ₹42.55 crore for Q4 FY25 (Jan–Mar 2025), on a consolidated basis.
| Item | Q4 FY25 | Q4 FY24 | YoY | Q3 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 460.22 | — | — | 430.72 | +6.8% |
| Other income | 15.43 | — | — | 12.71 | +21.4% |
| Total income | 475.65 | — | — | 443.43 | +7.3% |
| Profit before tax | 58.52 | — | — | 40.99 | +42.8% |
| Net profit for the period | 42.55 | — | — | 28.24 | +50.7% |
| Attributable to shareholders of the company | 32.57 | — | — | 22.34 | +45.8% |
| EPS, basic (₹) | 1.04 | — | — | 0.73 | +43.3% |
| Net margin (%) | 9.2 | — | 6.6 |
| Item | Q4 FY25 | Q4 FY24 | YoY | Q3 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 281.02 | — | — | 267.93 | +4.9% |
| Other income | 26.93 | — | — | 10.48 | +157.0% |
| Total income | 307.95 | — | — | 278.41 | +10.6% |
| Profit before tax | 34.05 | — | — | 12.10 | +181.4% |
| Net profit for the period | 26.51 | — | — | 7.62 | +247.9% |
| EPS, basic (₹) | 0.85 | — | — | 0.25 | +240.0% |
| Net margin (%) | 9.4 | — | 2.8 |
Consolidated
- Filed with BSE
- 29 May 2025, 17:36 IST
- Board meeting
- 28 May 2025
- Period
- 01 Jan 2025 to 31 Mar 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 29 May 2025, 17:36 IST
- Board meeting
- 28 May 2025
- Period
- 01 Jan 2025 to 31 Mar 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE